A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab
Mark Korpics, Mei‐Yin C. Polley, Sandeep R. Bhave, Gage Redler, Sean P. Pitroda, Jason J. Luke, Steven J. Chmura
Topics & Concepts
MedicinePembrolizumabConfidence intervalHazard ratioProportional hazards modelInternal medicineOncologyLogistic regressionOdds ratioPercentileImmunotherapyNuclear medicineRadiologyCancerMathematicsStatisticsRadiomics and Machine Learning in Medical ImagingCancer Immunotherapy and BiomarkersAdvanced X-ray and CT Imaging